Search for: "Steven B. Willis" Results 1 - 20 of 40
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jan 2017, 6:45 am by Brian Cordery
Brian CorderyBristowsby Steven Willis In a judgment handed down at the end of last week, Arnold J has indicated his intention to make a reference to the CJEU concerning the interpretation of Article 3(d) of the SPC Regulation i.e. the requirement for the marketing authorisation (“MA”) on which an SPC application is based to be the first MA placing the product (active ingredient or combination of active ingredients) on the market as a medicinal product. [read post]
13 Oct 2016, 6:50 am by Brian Cordery
Brian CorderyBristowsby Brian Cordery, Rachel Mumby and Steven Willis Media attention at the English High Court today may have been focussed on the Article 50 challenge but for many patent lawyers operating in the life sciences sector, of equal or greater importance was the handing down of the long-awaited judgment in the Lyrica appeal. [read post]
9 Nov 2016, 4:53 am by Brian Cordery
Brian CorderyBristowsby Steven Willis Yesterday, the Court of Appeal handed down its decision in Idenix v Gilead [2016] EWCA Civ 1089, a dispute involving SOVALDI® (sofosbuvir), which is sold by Gilead as a treatment for chronic hepatitis C infection in adults. [read post]
16 Feb 2021, 9:01 pm by Michael C. Dorf
Supreme Court rejected an emergency application from the State of Alabama, which had asked the Justices to lift a stay on the execution of Willie B. [read post]
3 Aug 2009, 3:19 am
October 1996 - The Judicial CornerFrom District Judge Willie B. [read post]
2 Aug 2016, 8:45 am by azatty
Vakula as President-Elect, Jeffrey Willis as First Vice President, Steven A. [read post]
22 Dec 2016, 9:10 am by Brian Cordery
Brian CorderyBristowsby Steven Willis Yesterday, the Patents Court handed down yet another decision in the Sisyphean pregablin litigation, this time refusing Sandoz’ application to vary the Order for Injunction which resulted from Arnold J’s October 2015 decision (“Sandoz I”) to injunct Sandoz following its launch of a full label pregabalin product (“Pregabalin Sandoz”). [read post]
22 Sep 2020, 4:00 am by Comunicaciones_MJ
Recordó un viaje Lisboa que realizó con Stevens semanas antes de su deceso. [read post]
22 Nov 2019, 5:51 am
Securities and Exchange Commission, on Wednesday, November 20, 2019 Tags: Agency costs, Disclosure, Institutional Investors, Political spending, SEC, SEC rulemaking, Securities regulation, Shareholder voting, Transparency Supreme Court Review of SEC’s Authority to Seek Disgorgement Posted by Greg Andres, Robert Cohen and Paul Nathanson, Davis Polk & Wardwell LLP, on Thursday, November 21, 2019 Tags: Disgorgement, Rule… [read post]
22 Jul 2012, 4:33 pm by Ira Meislik
It could be: (a) yes; (b) no, not at all; (c) some parts yes, and some parts no; (d) no, but it will be treated as if it were; and (e) no, but it may affect the parties’ later agreement. [read post]
12 Feb 2024, 9:47 am by Reference Staff
 BlummHomewaters: A Human and Natural History of Puget Sound (2022) by David B. [read post]
1 Apr 2017, 12:32 pm by Harold O'Grady
Hymowitz Law Professors: Three Centuries of Shaping American Law by Stephen B. [read post]
7 Jun 2019, 6:09 am
Mitchell, and Brett Atanasio, WilmerHale, on Sunday, June 2, 2019 Tags: Inside information, Insider trading, Liability standards, Section 10(b), Securities enforcement, U.S. federal courts Proposed Amendments to Delaware’s LLC and Partnership Acts Posted by John D. [read post]
5 Nov 2009, 5:33 pm by Paul Karlsgodt
The discussion then turned to “hybrid” class actions that seek to combine elements from Rule 23(b)(2) and Rule 23(b)(3) to award injunctive relief and monetary damages. [read post]